Login / Signup

An Unusual Case of Delayed-Onset Rituximab-Induced Ventricular Tachycardia: A Case Report.

Gevorg ArabyanRaphi HambartzhumianAnthony Martin LimMarrey QuizonJulia OberndorfJonathan Abaya GhazalehDinesh Sharma
Published in: Journal of investigative medicine high impact case reports (2024)
Cardiac disease associated with cancer treatment is a common adverse effect that is well-treated with appropriate monitoring. However, some cardiac adverse effects with cancer treatment are not well-understood, in particular rituximab-associated ventricular tachycardia. We present the fourth case of rituximab-associated ventricular tachycardia in a patient who is rituximab-naive and who does not have known cardiac disease history. This patient developed non-sustained polymorphic ventricular tachycardia 14 hours after rituximab was started and 6 hours after it was stopped, and after extensive monitoring including a 30-day event monitor, did not develop further significant runs of ventricular tachycardia.
Keyphrases
  • diffuse large b cell lymphoma
  • chronic lymphocytic leukemia
  • hodgkin lymphoma
  • left ventricular
  • emergency department
  • oxidative stress
  • high glucose
  • atrial fibrillation